136285-67-1 (2-[[(2'-氰基联苯-4-基)甲基]氨基]-3-硝基苯甲酸乙酯,Ethyl 2-N-(2'-Cyanobiphenyl-4-yl)methylamino-3-nitrobenzoate)

2-[[(2'-氰基联苯-4-基)甲基]氨基]-3-硝基苯甲酸乙酯;2 -(((2'-氰基 -[1,1'-联苯] -4-基)甲基)氨基)-3-硝基苯甲酸乙酯;2-[[(2’-氰基联苯-4-基)甲基]氨基]-3-硝基苯甲酸乙酯;2-[[(2''''-氰基联苯-4-基)甲基]氨基]-3-硝基苯甲酸乙酯;2-[[(2-氰基联苯-4-基)甲基]氨基]-3-硝基苯甲酸乙酯;坎地沙坦酯中间体 C4;坎地沙坦酯中间体(乙酯C4) ;坎地沙坦酯中间体乙酯C4;坎地沙坦中间体c4;2-[[(2'-氰基联苯-4-基)甲基]氨基]-3-硝基苯甲酸乙酯,坎地沙坦酯;阿奇沙坦中间体;坎地沙坦酯中间体C4;2-[[(2`-氰基联苯-4-基)甲基]氨基]-3-硝基苯甲酸乙酯;坎地沙坦杂质4;

Ethyl-2-[[(2'-cyanobiphenyl-4-yl)methyl]amino]-3-nitrobenzoate;2-[[(2'-Cyano[1,1'-biphenyl]-4-yl)methyl]amino]-3-nitro-benzoic acid ethyl ester;Ethyl-2-[(2′-cyanobiphenyl-4-yl)methylamino]-3-nitrobenzoate;ethyl 2-[[4-(2-cyanophenyl)phenyl]methylamino]-3-nitrobenzoate;Candesartan Impurity 4;ethyl-2-(((2'-cyanobiphenyl-4-yl)methyl)amino)-3-nitrobenzoate;Ethyl-2-[[(2 inverted exclamation marka-cyanobiphenyl-4-yl)amino]-3-nitrobenzoate;CS-0445295;FT-0643253;136285-67-1;J-006828;AMY37071;Ethyl 2-(((2'-cyano-[1,1'-biphenyl]-4-yl)methyl)amino)-3-nitrobenzoate;DTXSID20475918;Ethyl 2-[(2'-cyanobiphenyl-4-yl)methyl]amino-3-nitrobenzoate;AC-27008;ethyl 2-[(2'cyanobiphenyl-4-yl]-methyl]amino-3-nitrobenzoate;Ethyl 2-{[(2'-cyano[1,1'-biphenyl]-4-yl)methyl]amino}-3-nitrobenzoate;2,5,6-TRIMETHYL-3-ETHYLBENZOXAZOLIUMIODIDE;BCP13069;2-[[(2/'-Cyano[1,1/'-biphenyl]-4-yl)methyl]amino]-3-nitro-benzoic acid ethyl ester;O11737;AKOS015889761;CHPMKOFPDCKNBG-UHFFFAOYSA-N;SCHEMBL3976878;DS-13833;ethyl 2-((2'-cyanobiphenyl-4-yl)methylamino)-3-nitrobenzoate;2-(((2'-cyano(1,1'-biphenyl)-4-yl)methyl)amino)-3-nitrobenzoic acid ethyl ester;Ethyl 2-[N-[(2'-Cyanobiphenyl-4-yl)methyl]amino]-3-nitrobenzoate;ETHYL(2-ETHOXY-1-BENZIMIDAZOLE)-7-CARBOXYLATE;DB-042338;Ethyl-2-[[(2\\'-cyanobiphenyl-4-yl)methyl]amino]-3-nitrobenzoate;Benzoic acid, 2-[[(2'-cyano[1,1'-biphenyl]-4-yl)methyl]amino]-3-nitro-, ethyl ester; Ethyl 2-[N-[(2'-cyanobiphenyl-4-yl)methyl]amino]-3-nitrobenzoate;

MFCD09030634

CHPMKOFPDCKNBG-UHFFFAOYSA-N

1S/C23H19N3O4/c1-2-30-23(27)20-8-5-9-21(26(28)29)22(20)25-15-16-10-12-17(13-11-16)19-7-4-3-6-18(19)14-24/h3-13,25H,2,15H2,1H3

O(CC)C(C1C=CC=C(C=1NCC1C=CC(C2C=CC=CC=2C#N)=CC=1)[N+](=O)[O-])=O

新型非肽类长效ATII受体拮抗剂,高效抗高血压原料药坎地沙坦酯中间体。